JD.COM Pharmacy is the first large-scale comprehensive Internet e-commerce platform officially launched by JD.COM to carry out self-operated drug retail business; As the core platform of JD Health pharmaceutical supply chain business, it has grown from the initial pharmaceutical retail business to an influential online and offline integrated pharmaceutical retail marketing platform in the industry.
On this basis, JD.COM Pharmacy has deepened its cooperation with global medical and health brand partners, continuously improved its supply chain system covering all channels online and offline, comprehensively improved its professional service capabilities, and promoted the digital and intelligent transformation and upgrading of the pharmaceutical industry? .
Business trends
2065438+In May 2008, Bayer announced that it had signed a strategic framework agreement with JD.COM Pharmacy.
In May, 2020, JD.COM Pharmacy announced that it would upgrade its cooperation with Boehringer Ingelheim.
In August, 2020, Levatinib, a targeted drug for liver cancer in China, was listed in JD.COM pharmacy.
In 2020, Sinimod, a national first-class drug for treating multiple sclerosis, was launched on the JD.COM platform.
On September 19, 2020, AstraZeneca lung cancer drugs gefitinib (trade name: Iressa) and oxitinib (trade name: Teressa) were listed in JD.COM pharmacies in "self-operated mode".
The original hypoglycemic drug "Total Alkaloids from Mulberry Branches" with independent intellectual property rights in China was exclusively launched on the Internet of JD.COM Pharmacy.
In May, 2002 1, NMPA released a new drug1independently developed by Baekje Shenzhou. (Pambali Capsule) Approval information.
In May of 20021year, JD.COM Pharmacy has cooperated with more than 92% of the top 50 multinational pharmaceutical companies in the world and 97% of the top 50 pharmaceutical companies in China 100.